Understanding the Side Effects of Wegovy: What to Expect

Last reviewed: June 25, 2026

Last updated: June 25, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide is a GLP-1 receptor agonist that helps regulate blood sugar and appetite by mimicking a natural hormone in your gut. While clinical trials show semaglutide produces meaningful weight loss results, many patients experience side effects during the initial weeks of treatment. Understanding what to expect helps you stay committed to your therapy and manage symptoms effectively.

Common Semaglutide Side Effects and Timeline

The most frequently reported side effects of semaglutide include nausea, vomiting, constipation, and diarrhea. These gastrointestinal symptoms typically appear within the first few days of starting therapy and often peak during the first two to three weeks. Appetite suppression is also common and intentional—it represents the medication working as designed to reduce hunger signals in your brain.

Most patients experience symptom improvement by week four as their digestive system adapts to semaglutide's effects. Nausea severity varies widely depending on individual metabolism, starting dose, and how quickly your doctor increases your dosage. The key principle behind PlexusDx dosing is gradual escalation: your dose may need to go up over time, but your price remains flat from month one, allowing your body time to adjust without financial stress.

Managing Nausea and Gastrointestinal Symptoms

Dietary modifications are your first defense against nausea while taking semaglutide. Eating smaller, more frequent meals; avoiding high-fat foods; and staying hydrated can significantly reduce stomach discomfort. Many patients find that ginger tea, peppermint, or over-the-counter antiemetics provide relief without interfering with semaglutide's effectiveness.

If nausea persists beyond the first month, your PlexusDx healthcare provider may recommend dose adjustment, timing changes, or temporary medication support. Some patients benefit from taking semaglutide with a small snack or at a different time of day. Moving your injection day slightly or spacing meals further apart also helps your system acclimate while maintaining therapeutic benefits.

Constipation, Diarrhea, and Digestive Health

Semaglutide slows gastric emptying—the rate at which food moves through your stomach into the small intestine. This mechanism aids weight loss but can shift your bowel patterns toward constipation or, less commonly, diarrhea. Increasing fiber intake gradually, drinking 8-10 glasses of water daily, and adding light exercise like walking supports normal digestive function while taking semaglutide.

Over-the-counter stool softeners or fiber supplements are safe to use alongside semaglutide if constipation becomes uncomfortable. Prune juice, psyllium husk, and magnesium citrate are gentle options that work with rather than against your medication. Most patients find their digestion normalizes within 6-8 weeks as their body establishes a new baseline with semaglutide's effects.

When to Contact Your Healthcare Provider

Seek immediate medical attention if you experience severe abdominal pain, persistent vomiting lasting more than a few hours, signs of dehydration, or difficulty keeping down liquids. These symptoms may indicate pancreatitis or other serious conditions requiring urgent evaluation. Your PlexusDx medical team is available to assess whether symptoms warrant dose adjustment, temporary pause, or further investigation.

Moderate side effects—nausea that improves with dietary changes, occasional loose stools, or appetite suppression—are expected and generally resolve without intervention. However, if side effects significantly impact your quality of life beyond week three, contact your provider immediately. PlexusDx offers personalized support because every patient's tolerance profile differs, and adjustments can often resolve discomfort while maintaining therapeutic progress.

Genetic Testing and Personalized Tolerance Prediction

The PlexusDx Precision Peptide Genetic Test analyzes GIPR (rs1800437) and MC4R (rs17782313) — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

The Precision Peptide Genetic Test maps 14 metabolic pathways and 150+ genetic insights specific to GLP-1 therapy response. Patients with certain genetic variants may experience milder nausea, faster adaptation, or better appetite suppression at lower doses. This $298 test after your first month of treatment empowers your PlexusDx provider to fine-tune your protocol based on your unique peptide biology rather than trial-and-error dosing.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

How long do semaglutide side effects typically last?

Most side effects peak during weeks one to three and improve significantly by week four to six as your body adapts. Nausea and gastrointestinal symptoms may persist longer in some patients, but dietary changes and dose adjustments usually resolve them within 8 weeks. Your PlexusDx healthcare team monitors your progress and adjusts your protocol to minimize discomfort.

Can I take medication to manage semaglutide nausea?

Yes, over-the-counter antiemetics like ondansetron (Zofran) or ginger supplements are safe alongside semaglutide and can provide relief during the adaptation period. Prescription anti-nausea medications are also available if needed. Always inform your PlexusDx provider about any additional medications you use to ensure compatibility.

Is it normal to lose appetite completely when starting semaglutide?

Significant appetite suppression is the intended mechanism of semaglutide and is expected when the dose is properly calibrated. However, you should still be able to eat enough to meet basic nutritional needs—typically 1,200 to 1,500 calories daily for most patients. If appetite suppression prevents adequate nutrition intake, contact your provider for dose adjustment.

What is PlexusDx's pricing structure for semaglutide?

PlexusDx compounded semaglutide injection is $189/mo month-to-month (or $149/mo on the 6-month plan) across all three commitment tiers, with no per-dose fee increases as your dose escalates. This flat-rate model means your price won't go up even if your clinical dose increases—a key advantage of precision therapy without financial surprises.

How does PlexusDx genetic testing help with side effects?

No — the Precision Peptide Genetic Test does not predict your response to semaglutide or any specific medication. It analyzes pathway-level variants (GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Are there serious side effects I should worry about with semaglutide?

Serious side effects are rare but include pancreatitis (severe abdominal pain), thyroid issues, and gallbladder problems. Patients with personal or family history of medullary thyroid cancer should not use semaglutide. PlexusDx screens for contraindications during your initial consultation and monitors you throughout treatment.

Related Reading

• Wegovy Side Effects
• Mounjaro Side Effects Plexusdx
• Glp 1 Side Effects Plexusdx
• Tirzepatide Vs Semaglutide Side Effects

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.